https://www.newswire.ca/news-releases/ontario-and-quebec-expand-public-coverage-of-repatha-r-for-eligible-recent-acute-coronary-syndrome-patients-852301586.html
ONTARIO AND QUEBEC EXPAND PUBLIC COVERAGE OF REPATHA® FOR ELIGIBLE RECENT ACUTE CORONARY SYNDROME...
Apr 7, 2026 - /CNW/ - Amgen Canada announced today that the Governments of Ontario and Quebec have expanded public reimbursement of Repatha® (evolocumab injection) for...
acute coronary syndromeontarioquebecexpandpublic